share_log

中红医疗(300981.SZ)：安全输注事业部产品目前主要客户为国内市场

China Red Medical (300981.SZ): The main customers of the Safety Infusion Division products are currently in the domestic market.

Gelonghui Finance ·  Jul 30 04:53

On July 30th, Gelunhui reported that Zhonghong Medical (300981.SZ) stated on the investor platform that its product of the safety infusion department currently has primarily domestic customers, so it is little affected by the above tariff. Regarding the increased tariff on rubber gloves, the company's main measures include: 1) expanding the market; for the international market, it proactively explores non-U.S. markets, increases the market share in other regions. For the domestic market, it takes various marketing strategies to promote its own brand, vigorously expands the domestic market, and diversifies market risks; 2) reducing costs, promoting digital construction, reducing energy consumption, enhancing cost advantages; 3) laying out overseas production bases, seeking suitable regions to set up overseas bases while actively looking for high-quality investment symbols overseas, and further improving the company's ability to resist risks and maintain the interests of shareholders through self-construction or merger and acquisition, laying out overseas production bases and dealing with the complex and volatile market environment.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment